Atrial fibrillation raises stroke risk fivefold. But what if blood thinners are too dangerous after a brain bleed or major fall? A new monthly injection, abelacimab, may prevent strokes without the bleeding risk of traditional anticoagulants. Is this the future for AFib patients who can’t take blood thinners? Cardiologist Dr. Alain Bouchard discusses this groundbreaking drug with Dr. Charles V. Pollack, a consultant clinical scientist and professional educator with Novartis, owner of abelac...
All content for MyHeart.net is the property of Dr. Alain Bouchard and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Atrial fibrillation raises stroke risk fivefold. But what if blood thinners are too dangerous after a brain bleed or major fall? A new monthly injection, abelacimab, may prevent strokes without the bleeding risk of traditional anticoagulants. Is this the future for AFib patients who can’t take blood thinners? Cardiologist Dr. Alain Bouchard discusses this groundbreaking drug with Dr. Charles V. Pollack, a consultant clinical scientist and professional educator with Novartis, owner of abelac...
Guarding Your Heart: A Practical Guide to Prevent Atrial Fibrillation
MyHeart.net
27 minutes
1 year ago
Guarding Your Heart: A Practical Guide to Prevent Atrial Fibrillation
Atrial Fibrillation (AFib) is a common heart rhythm disorder that can significantly impact a patient's quality of life and lifespan. The incidence and prevalence of Afib are increasing in the US and globally. Dr Alain Bouchard, MD discusses with Dr. Ibrahim Hanna, a clinical cardiac electrophysiologist in Birmingham, AL with over 25 years of experience in the medical field.
MyHeart.net
Atrial fibrillation raises stroke risk fivefold. But what if blood thinners are too dangerous after a brain bleed or major fall? A new monthly injection, abelacimab, may prevent strokes without the bleeding risk of traditional anticoagulants. Is this the future for AFib patients who can’t take blood thinners? Cardiologist Dr. Alain Bouchard discusses this groundbreaking drug with Dr. Charles V. Pollack, a consultant clinical scientist and professional educator with Novartis, owner of abelac...
